Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating umbilical cord-derived mesenchymal stem cell therapy for aplastic anemia, sponsored by Hebei Medical University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Umbilical Cord Derived Mesenchymal Stem Cells Therapy (umbilical cord-derived mesenchymal stem cell therapy)

Snippet

Sponsor: Hebei Medical University | Conditions: Aplastic Anemia | Phase 1 | Status: UNKNOWN